Clinical trial · Interventional
Physical Function and Activities of Daily Living in Cancer Patients During Chemotherapy
NCT02677129CI-TRIAL-00026940completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study is a randomized controlled trial with the aim to examine the feasibility and the effects of a home-based exercise intervention program on activities of daily living (ADL) in patients with advanced gastrointestinal cancer undergoing chemotherapeutic treatment. Further outcomes include functional and body status, quality of life, body composition, and chemotherapy completion rate. Study participants will be randomized to an exercise intervention group or a wait-list control group
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Gastrointestinal Cancer | Malignant Digestive System Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| home-based exercise intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- home-based exercise intervention
- description
- home-based exercise intervention: Endurance training (moderate intensity; walking), 3-5 times per week Patients will receive exercise counselling how to realize the planned intervention home-based. Further, they will be asked to fill out an exercise log. The study team will periodically review adherence to the intervention and identify problems.
- interventionNames
- Other: home-based exercise intervention
- type
- NO_INTERVENTION
- label
- Waiting control group
- description
- The wait list control group receives usual care over the study period. Usual care depends on the hospital guidelines as well as oncologists' and physicians' consideration.
Primary outcomes (1)
- measure
- Short Physical Performance Battery
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically classified gastrointestinal cancer * UICC III-IV * Prior to (planned) first-line chemotherapy (curative und palliative) * ≥50 years Exclusion Criteria: * ECOG \> 2 * Systemic diseases (MS, ALS) * disorders (neurological, skeletal, muscular, mental or cognitive) or drug use (irrespective of the cancer therapy) that may affect gait, balance or muscular strength * chronic infection, uncontrolled hypertension (diastolic pressure over 95 mmHg) * vestibulopathies * uncorrected visual deficits
References
Publications (0)
Data not yet available
No reference posted for this study.